Literature DB >> 16966221

Compartmentalization and evolution of feline immunodeficiency virus between the central nervous system and periphery following intracerebroventricular or systemic inoculation.

Pinghuang Liu1, Lola C Hudson, Mary B Tompkins, Thomas W Vahlenkamp, Rick B Meeker.   

Abstract

The emergence of distinct neuropathogenic strains resulting from the adaptation and the unique evolution of human immunodeficiency virus (HIV) in the brain may contribute to the development of HIV-induced neurological diseases. In this study, the authors tracked early changes in virus evolution and compartmentalization between peripheral tissues and the central nervous system (CNS) after intracerebroventricular (i.c.v.) or intraperitoneal (i.p.) inoculation of animals with cell-free feline immunodeficiency virus (FIV). Using the FIV-NCSU1 envelope V3-V4 heteroduplex tracking assay (HTA), the authors observed a rapid compartmentalization of envelope variants between the CNS and periphery. Animals receiving the i.c.v. inoculation showed two peaks of viral RNA in the cerebrospinal fluid (CSF) with very different HTA patterns. Compared to the initial viral peak in CSF, the second peak showed an increased compartmentalization from plasma, reduced viral diversity, and more divergence from the proviral DNA in peripheral blood mononuclear cells (PBMCs) and the choroid plexus. In contrast, changes in plasma over the same time period were small. Different animals harbored different FIV DNA genotypes with varied regional compartmentalization within the brain. These results demonstrated that the virus within the CNS experienced a relatively independent but variable evolution from the periphery. Initial penetration of virus into the CSF facilitated the development of brain-specific reservoirs and viral diversification within the CNS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16966221      PMCID: PMC3130299          DOI: 10.1080/13550280600889575

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  46 in total

1.  Structural and functional evolution of human immunodeficiency virus type 1 long terminal repeat CCAAT/enhancer binding protein sites and their use as molecular markers for central nervous system disease progression.

Authors:  Tricia H Hogan; Devin L Stauff; Fred C Krebs; Suzanne Gartner; Shane J Quiterio; Brian Wigdahl
Journal:  J Neurovirol       Date:  2003-02       Impact factor: 2.643

2.  In vivo lymphocyte tropism of feline immunodeficiency virus.

Authors:  R V English; C M Johnson; D H Gebhard; M B Tompkins
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

3.  Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment.

Authors:  Theresa K Smit; Bruce J Brew; Wallace Tourtellotte; Susan Morgello; Benjamin B Gelman; Nitin K Saksena
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

4.  Feline immunodeficiency virus neurotropism: evidence that astrocytes and microglia are the primary target cells.

Authors:  S W Dow; M J Dreitz; E A Hoover
Journal:  Vet Immunol Immunopathol       Date:  1992-12       Impact factor: 2.046

5.  HIV-1 V3 domain variation in brain and spleen of children with AIDS: tissue-specific evolution within host-determined quasispecies.

Authors:  L G Epstein; C Kuiken; B M Blumberg; S Hartman; L R Sharer; M Clement; J Goudsmit
Journal:  Virology       Date:  1991-02       Impact factor: 3.616

6.  Early viral brain invasion in iatrogenic human immunodeficiency virus infection.

Authors:  L E Davis; B L Hjelle; V E Miller; D L Palmer; A L Llewellyn; T L Merlin; S A Young; R G Mills; W Wachsman; C A Wiley
Journal:  Neurology       Date:  1992-09       Impact factor: 9.910

7.  Human immunodeficiency virus and the brain: investigation of virus load and neuropathologic changes in pre-AIDS subjects.

Authors:  J E Bell; A Busuttil; J W Ironside; S Rebus; Y K Donaldson; P Simmonds; J F Peutherer
Journal:  J Infect Dis       Date:  1993-10       Impact factor: 5.226

8.  Human immunodeficiency virus type 1 nef quasispecies in pathological tissue.

Authors:  B M Blumberg; L G Epstein; Y Saito; D Chen; L R Sharer; R Anand
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

9.  Dynamics of viral and proviral loads of feline immunodeficiency virus within the feline central nervous system during the acute phase following intravenous infection.

Authors:  G Ryan; D Klein; E Knapp; M J Hosie; T Grimes; M J E M F Mabruk; O Jarrett; J J Callanan
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

Review 10.  Comparative neurovirulence in lentiviral infections: The roles of viral molecular diversity and select proteases.

Authors:  Christopher Power; Kunyan Zhang; Guido van Marle
Journal:  J Neurovirol       Date:  2004       Impact factor: 2.643

View more
  14 in total

Review 1.  Editorial neuroAIDS review.

Authors:  Paul Shapshak; Pandjassarame Kangueane; Robert K Fujimura; Deborah Commins; Francesco Chiappelli; Elyse Singer; Andrew J Levine; Alireza Minagar; Francis J Novembre; Charurut Somboonwit; Avindra Nath; John T Sinnott
Journal:  AIDS       Date:  2011-01-14       Impact factor: 4.177

Review 2.  The neuropathogenesis of feline immunodeficiency virus infection: barriers to overcome.

Authors:  Nicola F Fletcher; Rick B Meeker; Lola C Hudson; John J Callanan
Journal:  Vet J       Date:  2010-04-24       Impact factor: 2.688

3.  Endothelial cell suppression of peripheral blood mononuclear cell trafficking in vitro during acute exposure to feline immunodeficiency virus.

Authors:  Lola C Hudson; Mary B Tompkins; Rick B Meeker
Journal:  Cell Tissue Res       Date:  2008-07-30       Impact factor: 5.249

Review 4.  NeuroAIDS: characteristics and diagnosis of the neurological complications of AIDS.

Authors:  Alireza Minagar; Deborah Commins; J Steven Alexander; Romy Hoque; Francesco Chiappelli; Elyse J Singer; Behrooz Nikbin; Paul Shapshak
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

Review 5.  Feline immunodeficiency virus neuropathogenesis: from cats to calcium.

Authors:  Rick B Meeker
Journal:  J Neuroimmune Pharmacol       Date:  2006-11-28       Impact factor: 4.147

6.  Ethanol suppression of peripheral blood mononuclear cell trafficking across brain endothelial cells in immunodeficiency virus infection.

Authors:  Lola C Hudson; Brenda A Colby; Rick B Meeker
Journal:  HIV AIDS (Auckl)       Date:  2010-01-28

7.  Study of compartmentalization in the visna clinical form of small ruminant lentivirus infection in sheep.

Authors:  Hugo Ramírez; Ramsés Reina; Luigi Bertolotti; Amaia Cenoz; Mirna-Margarita Hernández; Beatriz San Román; Idoia Glaria; Ximena de Andrés; Helena Crespo; Paula Jáuregui; Julio Benavides; Laura Polledo; Valentín Pérez; Juan F García-Marín; Sergio Rosati; Beatriz Amorena; Damián de Andrés
Journal:  BMC Vet Res       Date:  2012-01-26       Impact factor: 2.741

8.  Improved neurocognitive performance in FIV infected cats following treatment with the p75 neurotrophin receptor ligand LM11A-31.

Authors:  Jonathan E Fogle; Lola Hudson; Andrea Thomson; Barbara Sherman; Margaret Gruen; B Duncan Lacelles; Brenda M Colby; Gillian Clary; Frank Longo; Rick B Meeker
Journal:  J Neurovirol       Date:  2021-03-04       Impact factor: 3.739

Review 9.  Small ruminant lentiviruses: genetic variability, tropism and diagnosis.

Authors:  Hugo Ramírez; Ramsés Reina; Beatriz Amorena; Damián de Andrés; Humberto A Martínez
Journal:  Viruses       Date:  2013-04-23       Impact factor: 5.048

Review 10.  Comparative Analysis of Tat-Dependent and Tat-Deficient Natural Lentiviruses.

Authors:  Deepanwita Bose; Jean Gagnon; Yahia Chebloune
Journal:  Vet Sci       Date:  2015-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.